Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

ORGO

Insider Sentiment (TTM):

Last Purchase:2026-03-09Last Sale:2025-12-16Shares Purchased (TTM):15,000Shares Sold (TTM):387,957

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:59,371,976Shares Outstanding:127,797,013Institutional Ownership Pct.:46.46%

Earnings Market Reaction:

Filing Date:2026-08-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	46	91	94	64	73	110	136	94	90	89	104	98
Restricted Cash Current	1	1	1	1	1	1	1	1	1	1	0	1
Accounts Receivable Net Current	101	117	217	169	120	103	110	101	106	96	82	89
Inventory Net	29	28	30	40	33	29	26	27	27	28	28	28
Assets Held In Trust Current	4	2	2	4	5	7	-	-	-	-	-	-
Prepaid Expense And Other Assets Current	20	29	18	23	28	18	14	15	11	14	10	10
Assets Current	200	269	362	300	260	268	286	239	234	227	225	226
Property Plant And Equipment Net	102	104	104	78	76	76	89	90	90	114	116	118
Intangible Assets Net Excluding Goodwill	3	3	9	10	11	12	12	13	14	15	16	17
Goodwill	29	29	29	29	29	29	29	29	29	29	29	29
Operating Lease Right Of Use Asset	50	54	56	33	35	37	37	35	37	39	40	42
Deferred Income Tax Assets Net	0	45	30	46	42	41	39	36	34	28	28	30
Other Assets Noncurrent	23	16	9	14	9	6	5	5	6	7	6	1
Assets	406	520	599	510	461	467	498	446	443	458	460	463
Liabilities And Stockhold…
Secured Debt Current	-	-	-	-	-	-	-	6	6	5	5	5
Liabilities Current
Finance Lease Liability Current	-	1	9	1	1	1	1	1	1	1	1	1
Operating Lease Liability Current	4	5	5	5	5	4	4	4	4	5	5	13
Accounts Payable Current	29	29	32	40	30	25	29	24	29	23	31	27
Liabilities Current	57	76	100	90	66	65	77	77	86	83	81	81
Secured Long Term Debt	-	-	-	-	-	-	-	56	58	59	61	62
Finance Lease Liability Noncurrent	-	12	13	2	0	0	1	1	1	2	2	2
Operating Lease Liability Noncurrent	21	22	22	24	25	26	25	23	23	24	25	39
Other Liabilities Noncurrent	4	1	1	3	3	1	1	1	1	1	1	1
Liabilities	118	139	165	124	100	99	113	168	180	180	181	186
Temporary Equity Carrying Amount Attributable To P…	140	137	134	131	128	125	122	-	-	-	-	-
Stockholders Equity
Preferred Stock Value	-	0	-	-	-	0	-	-	-	-	-	-
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	301	301	303	302	302	302	303	326	324	321	320	317
Retained Earnings Accumulated Deficit	-153	-56	-3	-47	-68	-59	-40	-48	-60	-43	-41	-40
Stockholders Equity	148	245	300	255	233	243	263	279	264	278	279	277
Liabilities And Stockholders Equity	406	520	599	510	461	467	498	446	443	458	460	463
Allowance For Doubtful Accounts Receivable Current	-	-	16	-	-	-	10	-	-	-	7	-
Temporary Equity Par Or Stated Value Per Share	0	0	0	0	0	0	0	-	-	-	0	-
Temporary Equity Shares Authorized	0	0	0	0	0	0	0	-	-	-	0	-
Temporary Equity Shares Issued	0	0	0	0	0	0	0	-	-	-	0	-
Temporary Equity Shares Outstanding	0	0	0	0	0	0	0	-	-	-	0	-
Temporary Equity Liquidation Preference	148	145	142	139	137	134	131	-	-	-	0	-
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	1	1	1	1	1	1	1	1	1	1	1	1
Preferred Stock Shares Issued	-	-	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	-	-	0	0	0	0	0	-	-	-	0	-
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	400	400	400	400	400	400	400	400	400	400	400	400
Common Stock Shares Issued	129	129	128	128	128	128	126	133	133	133	132	132
Shares Outstanding	129	129	127	127	127	127	126	133	133	133	131	131

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	1.58%	-3.95%	-5.53%	-	-	-	-	-	-	-	-	-
2025	-48.69%	-31.27%	-5.81%	13.94%	-9.29%	-5.75%	33.16%	35.60%	0.77%	-35.41%	-32.43%	-34.86%
2024	20.61%	22.81%	42.11%	9.92%	10.31%	6.87%	6.67%	-10.14%	6.67%	58.96%	37.46%	0.33%
2023	-	-	-	-14.16%	-6.19%	-36.58%	38.58%	107.61%	78.17%	-26.89%	-18.77%	-23.25%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	3.52	3.53	3.62	3.32	3.95	4.12	3.69	3.09	2.73	2.74	2.80	2.77
Quick Ratio	2.66	2.78	3.14	2.63	3.03	3.40	3.18	2.54	2.29	2.24	2.31	2.31
Working Capital	143.34M	192.48M	262.06M	209.43M	194.38M	203.11M	208.46M	161.23M	148.47M	144.37M	144.54M	144.09M
Leverage & Debt
Debt to Equity	0.80	0.57	0.55	0.49	0.43	0.41	0.43	0.60	0.68	0.65	0.65	0.67
Interest Coverage TTM	-30.68	1.50	19.59	-3.98	-10.57	-11.44	-0.77	-6.06	-5.27	6.17	5.72	13.11
Debt Ratio	0.29	0.27	0.28	0.24	0.22	0.21	0.23	0.38	0.41	0.39	0.39	0.40
Efficiency & Turnover
Asset Turnover TTM	1.05	1.04	1.03	0.97	0.95	0.99	1.01	1.00	1.00	0.96	0.95	0.98
Days Sales Outstanding TTM	88.29	78.09	105.88	105.94	96.16	79.35	72.64	76.42	81.22	78.86	72.24	74.13
Receivables Turnover TTM	4.13	4.67	3.45	3.45	3.80	4.60	5.02	4.78	4.49	4.63	5.05	4.92
Per Share Metrics
Diluted EPS TTM	-0.70	-0.00	0.28	-0.01	-0.08	-0.14	-0.01	-0.06	-0.12	0.04	0.04	0.10
Free Cash Flow Per Share TTM	0.13	0.13	-0.19	-0.38	-0.34	-0.06	0.03	0.03	0.06	0.05	0.05	-0.03
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	-	-	-	-	-	75.85%	75.99%	75.29%	75.14%	75.07%	75.42%	76.43%
Operating Profit Margin TTM	-7.84%	0.50%	7.92%	-1.80%	-5.32%	-5.27%	-0.27%	-2.81%	-2.44%	2.91%	2.89%	5.01%
Net Profit Margin TTM	-19.72%	-0.06%	6.56%	-0.17%	-2.33%	-3.85%	-0.19%	-1.62%	-3.69%	1.34%	1.14%	2.90%
Growth Metrics
Net Revenue Growth (1Y)	6.50%	12.19%	17.04%	2.24%	-4.21%	5.35%	11.29%	1.34%	-1.96%	-5.62%	-3.94%	-3.07%
Net Income Growth (1Y)	799.70%	-98.39%	-4,052.19%	-89.26%	-39.38%	-404.09%	-118.95%	-156.78%	-264.66%	-56.86%	-68.16%	-78.24%
EPS Growth (1Y)	786.97%	-98.41%	-4,206.08%	-88.77%	-36.65%	-417.50%	-118.88%	-156.24%	-263.07%	-57.11%	-68.44%	-78.31%
Valuation Metrics
P/E TTM	-3.47	-1,066.48	17.73	-675.21	-46.29	-30.86	-449.68	-51.37	-22.44	64.41	108.54	32.12
P/B TTM	2.11	1.24	2.19	2.10	1.99	2.25	1.60	1.36	1.41	1.35	1.93	1.51
P/S TTM	0.68	0.59	1.16	1.15	1.08	1.19	0.87	0.83	0.83	0.86	1.24	0.93
Market Cap	312.68M	302.88M	656.50M	535.44M	464.28M	545.60M	421.35M	379.17M	371.20M	374.49M	536.74M	417.57M
Enterprise Value	265.84M	223.65M	584.40M	474.37M	391.86M	436.67M	287.09M	348.52M	346.66M	352.71M	501.60M	389.69M
Calculated Values
Free Cash Flow TTM	16.27M	17.08M	-24.46M	-48.03M	-42.74M	-7.00M	4.18M	3.89M	8.52M	6.81M	6.55M	-3.59M
Net Debt	-46.84M	-79.23M	-72.11M	-61.07M	-72.42M	-108.93M	-134.26M	-30.64M	-24.55M	-21.78M	-35.14M	-27.89M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-03-09Purchase

Owner: Driscoll, Michael Joseph

Title: -

Shares: 10,000

Price/Share: $2.67

Value: $26,700.00

Shares Owned: 225,707

Relationship: Director

Ownership: Direct

2026-03-09Purchase

Owner: Leibowitz, Arthur S

Title: -

Shares: 5,000

Price/Share: $2.68

Value: $13,400.00

Shares Owned: 291,014

Relationship: Director

Ownership: Direct

2025-12-16Sale

Owner: Nussdorf, Glenn H

Title: -

Shares: 200,000

Price/Share: $5.14

Value: $1,028,000.00

Shares Owned: 2,565,591

Relationship: Director

Ownership: Direct

2025-11-26Sale

Owner: Nussdorf, Glenn H

Title: -

Shares: 187,957

Price/Share: $5.29

Value: $994,292.53

Shares Owned: 2,765,591

Relationship: Director,TenPercentOwner

Ownership: Direct

2025-06-10Sale

Owner: Nussdorf, Glenn H

Title: -

Shares: 18,620

Price/Share: $3.56

Value: $66,287.20

Shares Owned: 335,719

Relationship: Director,TenPercentOwner

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-03-09	Driscoll, Michael Joseph	Director	-	Direct	Purchase	10,000	2.67	$26,700.00	225,707	4
2026-03-09	Leibowitz, Arthur S	Director	-	Direct	Purchase	5,000	2.68	$13,400.00	291,014	4
2025-12-16	Nussdorf, Glenn H	Director	-	Direct	Sale	200,000	5.14	$1,028,000.00	2,565,591	4
2025-11-26	Nussdorf, Glenn H	Director,TenPercentOwner	-	Direct	Sale	187,957	5.29	$994,292.53	2,765,591	4
2025-06-10	Nussdorf, Glenn H	Director,TenPercentOwner	-	Indirect	Sale	18,620	3.56	$66,287.20	335,719	4
2025-06-06	Freedman, Lori	Officer	Chief Admin. and Legal Officer	Direct	Purchase	9,022	2.99	$26,975.78	846,459	4
2025-05-15	Nussdorf, Glenn H	Director,TenPercentOwner	-	Indirect	Purchase	107,494	2.99	$321,407.06	358,495	4
2025-03-04	Driscoll, Michael Joseph	Director	-	Direct	Sale	25,000	5.10	$127,500.00	166,879	4
2024-12-16	Gillheeney, Gary S.	Director,Officer	President and CEO	Direct	Sale	5,585	3.49	$19,491.65	3,039,194	4
2024-12-12	Gillheeney, Gary S.	Director,Officer	President and CEO	Direct	Sale	43,359	3.55	$153,924.45	3,100,394	4
2024-12-09	Gillheeney, Gary S.	Director,Officer	President and CEO	Direct	Sale	41,052	3.52	$144,503.04	3,359,726	4
2024-01-10	Gn, 2016 Organo 10-Year G…	TenPercentOwner	-	Direct	Sale	17,972	4.28	$76,920.16	59,007,134	4
2024-01-10	Dennis, Erani 2012 Issue …	TenPercentOwner	-	Direct	Sale	17,972	4.28	$76,920.16	59,007,134	4
2023-04-12	Gn, 2016 Family Trust U/A…	Director,TenPercentOwner	-	Direct	Sale	25,000	2.07	$51,750.00	59,223,027	4
2023-04-12	Red, Holdings, Llc, Erani…	TenPercentOwner	-	Direct	Sale	25,000	2.07	$51,750.00	59,223,027	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

46.46%

Inst. Shares: 59,371,976

Shares Outstanding: 127,797,013

2025-12-31

52.44%

Inst. Shares: 66,459,544

Shares Outstanding: 126,738,136

2025-09-30

52.27%

Inst. Shares: 66,315,234

Shares Outstanding: 126,881,709

2025-06-30

52.18%

Inst. Shares: 66,189,854

Shares Outstanding: 126,853,536

2025-03-31

48.08%

Inst. Shares: 60,717,089

Shares Outstanding: 126,295,642

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	59,371,976	127,797,013	46.46%
2025-12-31	66,459,544	126,738,136	52.44%
2025-09-30	66,315,234	126,881,709	52.27%
2025-06-30	66,189,854	126,853,536	52.18%
2025-03-31	60,717,089	126,295,642	48.08%
2024-12-31	58,328,193	131,673,278	44.30%
2024-09-30	58,738,559	132,575,301	44.31%
2024-06-30	58,259,050	132,573,153	43.94%
2024-03-31	50,895,706	131,861,772	38.60%
2023-12-31	53,678,766	131,231,317	40.90%
2023-09-30	47,234,300	131,312,483	35.97%
2023-06-30	46,824,691	131,293,398	35.66%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Organogenesis Holdings Inc. (ORGO) — SEC Financial Statements & Analysis

Organogenesis Holdings Inc. (ORGO) is a pharmaceutical preparations company, incorporated in DE. Organogenesis Holdings Inc. trades on Nasdaq as: ORGO. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Organogenesis Holdings Inc. reported a 6.50% year-over-year revenue growth, a Gross Profit Margin of 75.85% (TTM), a Debt-to-Equity ratio of 0.80x, a Price-to-Sales (P/S) ratio of 0.68x (TTM), a Price-to-Book (P/B) ratio of 2.11x (TTM), at a market cap of $312.68M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 6.50%
Gross Profit Margin TTM: 75.85%
Debt To Equity: 0.80x
P/S TTM: 0.68x
P/B TTM: 2.11x
Market Cap: $312.68M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Organogenesis Holdings Inc. in?

Organogenesis Holdings Inc. (ORGO) operates in the Pharmaceutical Preparations industry.

What is ORGO's market cap?

Organogenesis Holdings Inc. (ORGO) has a market capitalization of $312.68M as of 2026-06-30.

What exchange does ORGO trade on?

Organogenesis Holdings Inc. (ORGO) trades on the Nasdaq.

Where is Organogenesis Holdings Inc. incorporated?

Organogenesis Holdings Inc. is incorporated in DE.